Search for: "Janssen Pharmaceuticals Inc"
Results 201 - 220
of 247
Sorted by Relevance
|
Sort by Date
15 Jul 2009, 5:15 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: European Commission Competition DG releases final report on pharmaceutical sector (IPKat) (PatLit) (BLOG@IP::JUR) (IAM) (Managing Intellectual Property) (Intellectual Property Watch) (The SPC Blog) (IAM) US: Follow-on biologics proposals considered by US Senate HELP Committee; Committee passes amendment for 12-year biologics exclusivity period… [read post]
27 Jul 2020, 5:14 am
Elmiron is manufactured by Janssen Pharmaceuticals, Inc., a division of Johnson & Johnson, and is touted as the “only oral medication FDA approved to treat the bladder pain or discomfort of interstitial cystitis (IC). [read post]
27 Jul 2020, 5:14 am
Elmiron is manufactured by Janssen Pharmaceuticals, Inc., a division of Johnson & Johnson, and is touted as the “only oral medication FDA approved to treat the bladder pain or discomfort of interstitial cystitis (IC). [read post]
31 Dec 2014, 5:00 am
Janssen Pharmaceutica, Inc., 144 So.3d 898 (La. 2014). [read post]
20 Dec 2023, 5:00 am
Janssen 2014). [read post]
30 Dec 2013, 5:25 am
Takeda Pharmaceutical Co. [read post]
13 May 2010, 12:27 pm
Janssen Pharmaceutica, Inc., 288 Fed. [read post]
17 Feb 2012, 11:29 am
Ortho-McNeil-Janssen Pharmaceuticals Inc., 2010 WL 3548474 (Pa. [read post]
5 Sep 2013, 12:24 pm
Ortho-McNeil-Janssen Pharmaceuticals, Inc., 808 F. [read post]
21 Jun 2018, 10:33 am
For now let me just say that one of the panic’s major elements is the pharmaceutical opiate fentanyl. [read post]
29 Feb 2008, 8:00 am
– Teva’s opposition proceedings regarding IL 130424 to Pfizer: (IP Factor), Thailand: Thai chief drug price negotiator removed from post: (GenericsWeb), Thailand: Compulsory licences cannot be revoked: (Generic Pharmaceuticals & IP), (more from Generic Pharmaceuticals & IP), UK: Court of Appeal for England and Wales hands down decision in Boehringer Ingelheim KG and Boehringer Ingelheim Pharma KG v Swingward Limited relating to repackaging… [read post]
13 Jun 2011, 5:32 pm
Paliperidone FDA approved INVEGA on December 19, 2006 under NDA No. 21-999 and granted the sponsor, Ortho-McNeil-Janssen Pharmaceuticals, Inc. [read post]
24 Feb 2011, 1:49 pm
Janssen Pharmaceutica, Inc., 2006 WL 3665417, at *4 n.2 (S.D. [read post]
3 Sep 2015, 6:36 am
Am., Inc., 961 F. [read post]
22 Dec 2011, 11:59 am
Janssen Pharmaceuticals, Inc., 951 N.E.2d 1238 (Ill. [read post]
7 Jan 2010, 10:36 am
Wyeth, Inc., 2007 WL 2458021 (E.D. [read post]
18 Apr 2012, 1:29 pm
Janssen Pharmaceuticals, Inc., 951 N.E.2d 1238 (Ill. [read post]
1 Oct 2009, 2:14 am
Mylan Pharmaceuticals, 2008 WL 3540462 (N.D.W. [read post]
20 Mar 2015, 9:16 am
Ortho-McNeil-Janssen Pharmaceuticals, Inc., No. 2012-206987, 2015 WL 775094 (S.C. [read post]
4 May 2011, 7:52 am
Brand Name Opioid Products Generic Name Trade Name Applicant/Sponsors Fentanyl Duragesic Extended Release Transdermal System Ortho McNeil Janssen Hydromorphone *Palladone Extended Release Capsules Purdue Pharma Methadone Dolophine Tablets Roxanne Morphine Avinza® Extended Release Capsules King Pharms Morphine Kadian® Extended Release Capsules Actavis Morphine MS Contin Extended Release Tablets Purdue Pharma… [read post]
